Skip navigation

AI-Enabled Clinical Trials: A Multiomic Roadmap to Success

Image Credit: © Kaikoro –

June 3, 2024

by Niven Narain, PhD, President & CEO, BPGbio

How artificial intelligence can aid in selecting patients, leveraging safety insights, and optimizing combination therapies.

Conversations around the impact of artificial intelligence (AI) in the pharmaceutical industry seem to be everywhere, with AI often hailed as the solution to the perennial problem of the exorbitant cost to develop a new medicine. In these discussions, AI is often portrayed as a tool to improve the speed of compound identification. But while others debate whether the value of investments flowing into companies purporting to apply AI to drug discovery and development, overlooked is another area where AI can drive critical impact in drug development: designing more successful clinical trials.


Please visit Applied Clinical Trials to read more!